These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 28832550)
21. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance. Samotus O; Lee J; Jog M J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988 [TBL] [Abstract][Full Text] [Related]
22. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment]. Domzał TM Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249 [TBL] [Abstract][Full Text] [Related]
23. [Treatment of focal dystonia with botulinum toxin A]. Sojer M; Wissel J; Müller J; Poewe W Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045 [TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial. Pappert EJ; Germanson T; Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274 [TBL] [Abstract][Full Text] [Related]
25. Involvement of obliquus capitis inferior muscle in dystonic head tremor. Schramm A; Huber D; Möbius C; Münchau A; Kohl Z; Bäumer T Parkinsonism Relat Disord; 2017 Nov; 44():119-123. PubMed ID: 28802760 [TBL] [Abstract][Full Text] [Related]
26. A methodological approach for botulinum neurotoxin injections to the longus colli muscle in dystonic anterocollis: A case series of 4 patients and a literature review. Seliverstov Y; Arestov S; Klyushnikov S; Shpilyukova Y; Illarioshkin S J Clin Neurosci; 2020 Oct; 80():188-194. PubMed ID: 33099344 [TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247 [TBL] [Abstract][Full Text] [Related]
28. Clinical and polymyographic investigation of spasmodic torticollis. Deuschl G; Heinen F; Kleedorfer B; Wagner M; Lücking CH; Poewe W J Neurol; 1992 Jan; 239(1):9-15. PubMed ID: 1541974 [TBL] [Abstract][Full Text] [Related]
29. Electromyography in cervical dystonia: changes after botulinum and trihexyphenidyl. Brans JW; Aramideh M; Koelman JH; Lindeboom R; Speelman JD; Ongerboer de Visser BW Neurology; 1998 Sep; 51(3):815-9. PubMed ID: 9748032 [TBL] [Abstract][Full Text] [Related]
30. An analysis of the efficacy of botulinum neurotoxin type a in treating cervical dystonia. Zhou X; Li ZF; Guo XZ; Wei Q; Niu YN; Li M; Xia JN; Chen LP Technol Health Care; 2024; 32(4):2421-2430. PubMed ID: 38073352 [TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin treatment of axial and cervical dystonia. Benecke R; Dressler D Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602 [TBL] [Abstract][Full Text] [Related]
32. Treatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responses. Bhidayasiri R Parkinsonism Relat Disord; 2011 Nov; 17 Suppl 1():S20-4. PubMed ID: 21999891 [TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin and conservative treatment strategies in people with cervical dystonia: an online survey. Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; De Oliveira CQ; Verhagen AP J Neural Transm (Vienna); 2024 Jan; 131(1):43-51. PubMed ID: 37831150 [TBL] [Abstract][Full Text] [Related]
34. Fluoroscopic, EMG-guided injection of botulinum toxin into the longus colli for the treatment of anterocollis. Glass GA; Ku S; Ostrem JL; Heath S; Larson PS Parkinsonism Relat Disord; 2009 Sep; 15(8):610-3. PubMed ID: 19250855 [TBL] [Abstract][Full Text] [Related]
35. Effect of Botulinum Toxin on Non-Motor Symptoms in Cervical Dystonia. Costanzo M; Belvisi D; Berardelli I; Maraone A; Baione V; Ferrazzano G; Cutrona C; Leodori G; Pasquini M; Conte A; Fabbrini G; Defazio G; Berardelli A Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564651 [TBL] [Abstract][Full Text] [Related]
36. Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy. Yi YG; Kim K; Yi Y; Choi YA; Leigh JH; Bang MS Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772695 [TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin injections reduce associative plasticity in patients with primary dystonia. Kojovic M; Caronni A; Bologna M; Rothwell JC; Bhatia KP; Edwards MJ Mov Disord; 2011 Jun; 26(7):1282-9. PubMed ID: 21469207 [TBL] [Abstract][Full Text] [Related]
38. Descending control of muscles in patients with cervical dystonia. Tijssen MA; Münchau A; Marsden JF; Lees A; Bhatia KP; Brown P Mov Disord; 2002 May; 17(3):493-500. PubMed ID: 12112196 [TBL] [Abstract][Full Text] [Related]
39. The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia. Hefter H; Schomaecker I; Schomaecker M; Rosenthal D; Samadzadeh S Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357965 [TBL] [Abstract][Full Text] [Related]
40. Management of Anterocapitis and Anterocollis: A Novel Ultrasound Guided Approach Combined with Electromyography for Botulinum Toxin Injection of Longus Colli and Longus Capitis. Farrell M; Karp BI; Kassavetis P; Berrigan W; Yonter S; Ehrlich D; Alter KE Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 33008043 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]